34 completed. 34 Phase 2, 6 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 34 | Completed 34 |
| Phase 1 | 6 | Completed 6 |
| Phase 3 | 3 | Completed 3 |
Follow Tetanus: new trials by email Literature Review of Tetanus trials Research Report on Tetanus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants SNA02-48, Placebo, HTIG - Tetanus | Phase 1 / Phase 2 | Completed | Sinovac Life Sciences Co., Ltd. | 255 | 2025-04-28 | 2026-06-03 |
| A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp)), 23-valent Pneumococcal Polysaccharide Vaccine (PPV23), Tdcp - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | CanSino Biologics Inc. | 1820 | 2024-12-20 | 2026-08-26 |
| Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination | Phase 2 | Completed | ABO Holdings, Inc. | 107 | 2023-05-05 | 2026-07-02 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults GR2001, Placebo, HTIG - Tetanus | Phase 1 / Phase 2 | Completed | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 202 | 2023-03-04 | 2024-03-08 |
| Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers TNM002 (low dose), TNM002 (medium dose), TNM002 (high dose) - Tetanus | Phase 2 | Completed | Zhuhai Trinomab Pharmaceutical Co., Ltd. | 240 | 2022-04-18 | 2025-09-16 |
| Tdap Vaccine Safety for Plasma Donors Adacel - Tetanus | Phase 2 / Phase 3 | Completed | GCAM Inc. | 110 | 2020-02-03 | 2022-12-06 |
| A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS RSV Vaccine, Tdap, Placebo - Respiratory Tract Infection | Phase 2 | Completed | Pfizer | 713 | 2019-10-01 | 2021-02-15 |
| Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants Tetanus and Diphtheria Toxoids Adsorbed, Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum hydroxide - Clostridium Difficile Immunisation, Diphtheria | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 399 | 2019-01-24 | 2025-05-21 |
| Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains) - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | LG Chem | 60 | 2018-07-18 | 2026-09-03 |
| A Study of AV0328 Administered to Healthy Adult Volunteers AV0328 - Cohort 1, AV0328 - Cohort 2, AV0328 - Cohort 3 - PNAG-expressing Pathogenic Microbes Vaccine | Phase 1 / Phase 2 | Completed | Alopexx Vaccine, LLC | 16 | 2017-03-22 | 2019-03-19 |
| Intrathecal Tetanus Immunoglobulin to Treat Tetanus Human tetanus immunoglobulin, Intramuscular antitoxin - Tetanus | Phase 1 / Phase 2 | Completed | Oxford University Clinical Research Unit, Vietnam | 272 | 2017-02-13 | 2020-05-29 |
| Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1, Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2, Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3 - Tetanus, Diphtheria | Phase 1 / Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 1363 | 2015-10-22 | 2022-03-23 |
| Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis - Pertussis, Tetanus | Phase 1 / Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 43 | 2012-09-01 | 2014-02-21 |
| Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) Infanrix hexa, Prevenar 13, GSK217744 - Acellular Pertussis, Hepatitis B | Phase 2 | Completed | GlaxoSmithKline | 657 | 2011-10-14 | 2020-07-17 |
| Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) Infanrix hexa™, Prevenar 13®, GSK217744 - Tetanus, Poliomyelitis | Phase 2 | Completed | GlaxoSmithKline | 721 | 2010-12-09 | 2018-08-20 |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose GSK2202083A vaccine, Infanrix hexa™, Menjugate™ - Tetanus, Diphtheria | Phase 2 | Completed | GlaxoSmithKline | 391 | 2010-08-18 | 2020-01-21 |
| Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants GSK2202083A vaccine, Prevenar 13®, Infanrix hexa™ - Tetanus, Hepatitis B | Phase 2 | Completed | GlaxoSmithKline | 480 | 2010-05-17 | 2018-08-20 |
| Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers GSK2036874A vaccine, Zilbrix™/Hib vaccine, Poliorix™ - Haemophilus Influenzae Type b, Tetanus | Phase 2 | Completed | GlaxoSmithKline | 312 | 2010-05-13 | 2019-10-01 |
| Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age GSK2202083A vaccine, 10-valent pneumococcal vaccine (GSK 1024850A), Infanrix hexa™ - Tetanus, Diphtheria | Phase 2 | Completed | GlaxoSmithKline | 421 | 2009-08-13 | 2020-01-03 |
| Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients Levamisole, Placebo - Renal Dialysis | Phase 2 | Completed | Shiraz University of Medical Sciences | 40 | 2008-03-01 | 2013-07-26 |
Showing 20 of 34. Sign in to see all of them.
Diphtheria (26) · Hepatitis B (19) · Haemophilus Infections (15) · Poliomyelitis (15) · Whooping Cough (14) · Meningitis, Meningococcal (1) · Respiratory Tract Infections (1)
Bacterial Infections (34) · Bacterial Infections and Mycoses (34) · Clostridium Infections (34) · Gram-Positive Bacterial Infections (34) · Infections (34) · Actinomycetales Infections (26) · Corynebacterium Infections (26) · Gram-Negative Bacterial Infections (24) · Virus Diseases (20) · Blood-Borne Infections (19) · Communicable Diseases (19) · DNA Virus Infections (19) · Digestive System Diseases (19) · Hepadnaviridae Infections (19) · Hepatitis (19)
Tetanus Toxoid (8) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (8) · 13-valent pneumococcal vaccine (3) · adacel (3) · Diphtheria-Tetanus-acellular Pertussis Vaccines (2) · Hepatitis B Vaccines (2) · Poliovirus Vaccine, Inactivated (2) · Vaccines, Combined (2) · 10-valent pneumococcal vaccine (1) · DTaP-IPV-HB-PRP-T vaccine (1) · Drug Evaluation (1) · Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate (1) · Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine (1) · Hiberix (1) · Levamisole (1)
GlaxoSmithKline (15) · Sanofi Pasteur, a Sanofi Company (5) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · ABO Holdings, Inc. (1) · Alopexx Vaccine, LLC (1) · CanSino Biologics Inc. (1) · GCAM Inc. (1) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. (1) · LG Chem (1) · Oxford University Clinical Research Unit, Vietnam (1) · Pfizer (1) · Sanofi (1) · Shiraz University of Medical Sciences (1) · Sinovac Life Sciences Co., Ltd. (1) · Zhuhai Trinomab Pharmaceutical Co., Ltd. (1)
United States (9) · Philippines (5) · China (4) · Finland (4) · Canada (3) · Dominican Republic (2) · Germany (2) · Poland (2) · Argentina (1) · France (1) · Iran (1) · Japan (1) · Mali (1) · South Korea (1) · Vietnam (1)
Adam Thaler, DO (1) · Edison Alberto, MD (1) · Hal Landy, MD (1) · Hanqing He (1) · Jie Hou (1) · Jing Zhang, PHD (1) · Josefina Carlos, MD (1) · Minh Yen Lam, MD (1) · Mohamad Mahdi Sagheb, MD (1) · Wei Hu (1)
PMID 20657177, PMID 28340322, PMID 21372751, PMID 23241989, PMID 24341659, PMID 24346596, PMID 25540274, PMID 30809591, PMID 34637519, PMID 35561721, PMID 38586589
2009 (1), 2016 (1)